Navigation Links
First Ultrasound Thrombolysis in U.S. Performed at Emory University Hospital

Physicians at Emory University Hospital recently performed for the first time in the United States a procedure called Ultrasound Assisted Thrombolysis to destroy a deadly blood clot in a patient suffering from deep vein thrombosis.

The procedure was performed by Abbas Chamsuddin, MD, associate professor of interventional radiology in the Emory University School of Medicine, to relieve a major system of clotting that filled the veins of the patient's leg, pelvis and inferior vena cava leading up to the heart.

Deep vein thrombosis (DVT) is a blood clot in a deep vein, usually found in the legs. These clots can, in turn, form in superficial veins in deep veins. While blood clots in superficial veins rarely cause serious problems, clots in deep veins (deep vein thrombosis) require immediate medical care.

According to Dr. Chamsuddin, ultrasound assisted thrombolysis incorporates use of a tiny catheter that houses an ultrasound wire and medications which slowly dissolve the clots.

"Ultrasound assisted thrombolysis uses a catheter that houses an ultrasound wire which causes fragmentation of the clot, while dripping clot busting medications are then delivered," says Dr. Chamsuddin."

The catheter-based drug delivery system combines the use of targeted drug delivery catheters and the therapeutic benefits of a high frequency low power ultrasound. The incorporation of ultrasound, says Dr. Chamsuddin, allows physicians to loosen tightly knit fabrics found within a blood clot called fibrin.

"The ultrasound helps temporarily loosen and separate the fibrin for more blood clot permeability," explains Dr. Chamsuddin. "The loosened fibrins then allow for reception of the infusion of clot-busting medications, which then slowly dissolve the blockage - usually within two to three days."

Emory houses two of the machines that are used for this procedure (called Peripheral Infusion Systems). < br>
Other treatments for deep vein clots typically include use of blood thinners such as heparin and warfarin. Heparin is given through a vein (intravenously, or IV) or as an injection. Warfarin is given as a pill. Treatment usually involves taking blood thinners for at least three months to prevent existing clots from growing.


Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:

(Date:11/25/2015)... ... ... Students and parents have something to be thankful for this Thanksgiving week ... California Casualty is proud to support the contest designed to utilize peer-to-peer ... the number one killer of young drivers. , Almost 1,000 entries of original ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
(Date:11/24/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced that Dr. Christine Milligan, Global Director, Strategic ... to be held at the InterContinental Seoul COEX Hotel, Seoul, Republic of Korea, ...
(Date:11/24/2015)... Boston, MA (PRWEB) , ... November 24, 2015 ... ... today announced that the organization will waive paid entry and parking fees at ... in Hingham, and Monument Mountain in Great Barrington in support of REI’s Black ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... United States to support their local poison centers through donations on Tuesday, Dec. ... calls it “a day that inspires people to collaborate in improving their ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
(Date:11/24/2015)... , November 24, 2015 st  Scientific ... North America (RSNA) taking place in Chicago ... Booth 1122, Hall A. --> st  Scientific Assembly and ... (RSNA) taking place in Chicago ... Hall A. --> Molecular Dynamics will present its revolutionary ...
(Date:11/24/2015)... , November 24, 2015 The uptake of ... will be a key driver of market growth to 2021, ... recently approved and pipeline premium products for Type 1 Diabetes Mellitus (T1DM), ... says GBI Research . --> The uptake ... (T1DM), will be a key driver of market growth to 2021, ...
Breaking Medicine Technology: